The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
UniProt A0AAX6R0R7 is consistent with the naked mole-rat orthologue of CD44, not an unrelated same-symbol protein. The supplied organism (Heterocephalus glaber), gene symbol (Cd44), receptor description, and InterPro assignments—CD44 antigen, CD44-antigen-like, Link domain, and C-type-lectin-like/CTDL fold—are mutually compatible with canonical mammalian CD44. No conflicting H. glaber gene identity was found. However, the accession appears computationally annotated, and no publication experimentally characterizing the purified A0AAX6R0R7 polypeptide itself was located.
The most defensible primary annotation is: a non-enzymatic, single-pass plasma-membrane adhesion and extracellular-matrix receptor whose extracellular Link module binds hyaluronan (HA), while its short cytoplasmic tail couples the extracellular HA-rich matrix to cortical actin and signaling proteins. In naked mole-rat fibroblasts, the best-supported specialized role is participation in an HA-dependent anti-transformation/contact-inhibition program and in HA-mediated stress resistance. It is not an enzyme or transporter and therefore has neither a catalytic reaction nor a transported substrate.
| Annotation aspect | Conclusion | Evidence type | Confidence | Key caveat |
|---|---|---|---|---|
| Identity and domains | UniProt A0AAX6R0R7 is annotated as H. glaber Cd44 encoding a CD44 antigen/hyaluronate receptor with CD44 antigen and Link/C-type lectin-like domains, matching canonical mammalian CD44 architecture. | accession/domain annotation supplied by user | High | Accession-specific wet-lab validation was not located in the retrieved literature. |
| Plasma membrane topology | Cd44 is best annotated as a single-pass plasma-membrane glycoprotein with extracellular HA-binding Link module, membrane-proximal stem region, transmembrane helix, and short cytoplasmic tail lacking intrinsic catalytic activity. (skandalis2023cd44intracellulardomain pages 1-2, skandalis2023cd44intracellulardomain pages 2-4, cowman2023functionalorganizationof pages 5-5) | mammalian orthology inference | High | Topology is inferred from conserved mammalian CD44, not directly shown for A0AAX6R0R7. |
| Primary molecular function | The primary function is non-enzymatic extracellular-matrix receptor activity, especially binding hyaluronan (HA) to regulate adhesion, pericellular matrix organization, and context-dependent signaling. (skandalis2023cd44intracellulardomain pages 1-2, cowman2023functionalorganizationof pages 5-5) | mammalian orthology inference | High | Direct ligand-binding biophysics for naked mole-rat CD44 protein itself were not retrieved. |
| HA receptor role in naked mole-rat biology | In naked mole-rat cells, HA signaling through CD44 is implicated in the distinctive anti-transformation phenotype; CD44-blocking antibody disrupted HA-dependent resistance to oncogenic transformation in fibroblasts. (tian2013highmolecularmasshyaluronanmediates pages 1-7) | direct naked mole-rat experiment | High | Evidence is largely cell-culture based and does not isolate every downstream mediator. |
| CD44–NF2/contact inhibition axis | Naked mole-rat cancer resistance is strongly linked to HA-dependent early contact inhibition, with NF2/phospho-NF2 and p16 changes reported in the pathway; CD44 is the implicated HA receptor mediating this axis. (tian2013highmolecularmasshyaluronanmediates pages 1-7, tian2013highmolecularmasshyaluronanmediates pages 7-9) | direct naked mole-rat experiment | Moderate-High | Much of the pathway assignment combines direct perturbation with mechanistic interpretation from broader mammalian CD44 biology. |
| vHMM-HA cytoprotection and p53 | Very-high-molecular-mass HA from naked mole-rat (>6.1 MDa in this study) protected cells from stress-induced arrest/death in a CD44-dependent, p53-dependent manner and suppressed CD44 protein–protein interactions relative to shorter HA. (takasugi2020nakedmoleratveryhighmolecularmass pages 1-2) | direct naked mole-rat experiment | High | Experiments emphasize HA preparations and cellular responses; they do not provide accession-specific structural data for Cd44. |
| HA size in naked mole-rat tissues | HA abundance is higher in naked mole-rat tissues than comparators, but reported size is controversial: Tian 2013 reported 6–12 MDa HA, whereas del Marmol 2021 found maxima around 2.5 MDa and no ≥4 MDa HA. (marmol2021abundanceandsize pages 2-4, marmol2021abundanceandsize pages 1-2) | direct naked mole-rat experiment | Moderate | Methodological differences and incomplete replication leave the exact in vivo HA size distribution unresolved. |
| Cytoskeletal and signaling partners | CD44 commonly couples to ERM proteins, ankyrin, merlin/NF2, IQGAP1, lipid rafts, and cleavage-dependent signaling modules that regulate migration, trafficking, HA endocytosis, and receptor cross-talk. (skandalis2023cd44intracellulardomain pages 2-4, skandalis2023cd44intracellulardomain pages 4-5, skandalis2023cd44intracellulardomain pages 5-7, cowman2023functionalorganizationof pages 8-8, cowman2023functionalorganizationof pages 9-9) | mammalian orthology inference | High | These partners are well established in mammals but were not directly mapped for H. glaber Cd44 in the retrieved studies. |
| Translational status | CD44 is an active biomarker and therapeutic-targeting area in oncology; a 2024 scoping review screened 12,659 records and included 40 studies, with most linking higher CD44 to worse chemotherapy outcomes, while HA-based delivery systems are in preclinical/limited translational use. No naked-mole-rat CD44-specific intervention is clinically implemented. (wu2024roleofcd44 pages 1-2, wu2024roleofcd44 pages 9-10, cirillo2023thehyaluronancd44axis pages 9-11, ziranu2024cd44anew pages 9-10) | direct naked mole-rat experiment | Moderate | Translational evidence is mostly from human cancer biomarker/therapy literature and HA platform technologies, not naked mole-rat Cd44 therapeutics. |
Table: This table separates what is directly demonstrated for naked mole-rat Cd44 biology from what is inferred from the supplied UniProt/domain annotation and broader mammalian CD44 literature. It is useful for functional annotation because it highlights both strong conclusions and the main uncertainties.
The supplied UniProt record names the product “CD44 antigen,” “hyaluronate receptor,” and “lymphocyte homing/adhesion receptor.” These are established names for the same multifunctional mammalian cell-surface glycoprotein. The supplied Link-domain and CD44-antigen InterPro assignments are particularly diagnostic: mammalian CD44 contains an N-terminal hyaluronan-binding domain incorporating a Link module. Current structural reviews place the mammalian HA-binding domain at approximately residues 21–178 and the core Link module at approximately residues 32–124. (cowman2023functionalorganizationof pages 5-5)
Canonical mammalian CD44 comprises an extracellular HA-binding region and variable membrane-proximal stem, one transmembrane helix, and a short cytoplasmic tail. Alternative splicing of stem-region exons generates standard and variant isoforms, while glycosylation and glycosaminoglycan substitution further diversify ligand binding. The HA-binding module, transmembrane segment, and intracellular tail are strongly conserved among mammals, supporting transfer of this architecture to A0AAX6R0R7. (skandalis2023cd44intracellulardomain pages 1-2, cowman2023functionalorganizationof pages 5-5)
Important evidence boundary: literature on human or mouse CD44 is useful for orthology-based annotation but is not direct proof that every ligand, isoform, modification, or signaling interaction occurs identically in naked mole-rat A0AAX6R0R7.
CD44’s principal ligand is hyaluronan, a large, non-sulfated extracellular glycosaminoglycan. Binding occurs through the extracellular Link-homology domain. Receptor avidity is controlled not only by intrinsic affinity but also by glycosylation, membrane clustering, lipid-raft partitioning, and HA polymer organization. CD44 can consequently organize a hydrated pericellular HA coat and mediate cell–matrix adhesion, migration, HA uptake, and context-dependent signaling. (skandalis2023cd44intracellulardomain pages 1-2, cowman2023functionalorganizationof pages 8-8, cowman2023functionalorganizationof pages 5-5)
CD44 possesses no intrinsic catalytic or kinase activity. Its signaling function is that of a scaffold/co-receptor. The conserved cytoplasmic tail binds ezrin, radixin, and moesin (ERM), ankyrin, and merlin/NF2, thereby connecting extracellular HA to cortical actin and signaling machinery. Additional interactions with IQGAP1 and Rho-family GTPase pathways help regulate polarity, membrane organization, chemotaxis, and migration. (skandalis2023cd44intracellulardomain pages 2-4, skandalis2023cd44intracellulardomain pages 4-5, skandalis2023cd44intracellulardomain pages 5-7)
Other reported mammalian extracellular partners include osteopontin, collagen, fibronectin, laminin, cytokines, chemokines, and growth factors. These secondary interactions can be isoform- and glycosylation-dependent and should be considered plausible rather than experimentally established for A0AAX6R0R7. (skandalis2023cd44intracellulardomain pages 1-2, cowman2023functionalorganizationof pages 5-5)
The functional protein is expected predominantly at the plasma membrane, with its glycosylated N-terminal domain exposed to the extracellular space/pericellular matrix, one membrane-spanning helix, and its C-terminal tail in the cytosol. This orientation permits simultaneous HA binding outside the cell and actin/signaling coupling inside it. The mammalian tail is approximately 72–73 amino acids and includes FERM/ERM-, ankyrin-, basolateral-targeting-, and PDZ-binding motifs. (skandalis2023cd44intracellulardomain pages 1-2, skandalis2023cd44intracellulardomain pages 2-4)
CD44 is dynamically internalized and recycled and contributes to HA endocytosis. Metalloproteinase-mediated ectodomain shedding can be followed by γ-secretase cleavage; the released intracellular fragment can enter the nucleus and affect transcription. These trafficking and cleavage mechanisms are well supported in other mammalian cells but have not been directly mapped for naked mole-rat Cd44. (skandalis2023cd44intracellulardomain pages 4-5, cowman2023functionalorganizationof pages 9-9)
Tian and colleagues reported that naked mole-rat fibroblasts produce unusually large HA and display pronounced contact inhibition. Blocking CD44-mediated HA signaling made adult naked mole-rat skin fibroblasts more susceptible to transformation by SV40 large T antigen plus oncogenic Ras. Independently reducing HA through Has2 knockdown or Hyal2 overexpression enabled transformed naked mole-rat cells to form soft-agar colonies, supporting a causal HA-receptor pathway rather than a simple expression correlation. NF2 phosphorylation and p16-related changes were associated with cell density and HA status. Published June 2013, Nature, DOI/URL: https://doi.org/10.1038/nature12234. (tian2013highmolecularmasshyaluronanmediates pages 1-7, tian2013highmolecularmasshyaluronanmediates pages 7-9)
The proposed pathway is therefore:
extracellular high-molecular-mass HA → CD44 engagement/organization → merlin/NF2 and cytoskeletal coupling → induction or reinforcement of density-dependent cell-cycle arrest → reduced susceptibility to oncogenic transformation.
CD44 is the receptor/scaffold in this model; HAS2 synthesizes the ligand, and hyaluronidases control its degradation. CD44 does not synthesize or degrade HA.
Takasugi and colleagues compared very-high-molecular-mass HA exceeding 6.1 MDa with shorter HMW-HA. The longer polymer protected naked mole-rat, mouse, and human cells from stress-induced cell-cycle arrest and death. The effect required CD44, suppressed CD44–CD44 protein interactions relative to shorter HA, altered CD44-dependent transcription associated with the p53 pathway, and partially attenuated p53 activity in a p53-dependent cytoprotective response. Published May 2020, Nature Communications, DOI/URL: https://doi.org/10.1038/s41467-020-16050-w. (takasugi2020nakedmoleratveryhighmolecularmass pages 1-2)
This result illustrates a critical modern concept: CD44 signaling is not simply “on” or “off.” HA size, conformation, receptor clustering, cellular context, and co-receptors can produce opposite biological outcomes.
The influential 2013 study reported HA of approximately 6–12 MDa, more than fivefold larger than mouse or human HA, and associated its persistence with reduced degradation and distinctive naked mole-rat HAS2 sequence features. (marmol2021abundanceandsize pages 2-4)
A 2021 independent re-evaluation using HA-binding-protein histochemistry, quantitative assays, chromatography, electrophoresis, transcriptomics, and zymography found greater HA abundance and average molecular mass in naked mole-rat samples than in comparison species, but a maximum near 2.5 MDa and no detectable HA at or above 4 MDa. It also found lower HYAL1 expression/activity in naked mole-rat than mouse lymph nodes and systematic elevation of Tnfaip6 and Hyal3. Published April 2021, Scientific Reports, DOI/URL: https://doi.org/10.1038/s41598-021-86967-9. (marmol2021abundanceandsize pages 1-2)
The authors identified methodological differences—including earlier use of less-specific staining and pulsed-field electrophoresis—and noted that the original tissue-size and early-contact-inhibition observations had not then been independently reproduced. Thus, elevated HA abundance and relatively high molecular mass are credible, but the exact in-vivo upper size and the universality of “6–12 MDa” remain unresolved. (marmol2021abundanceandsize pages 1-2, marmol2021abundanceandsize pages 2-4)
This dispute concerns the ligand, not the identity of Cd44 as an HA receptor. It does, however, affect mechanistic claims that require an exceptionally long polymer.
The HA–CD44–NF2/contact-inhibition axis is the most relevant precise pathway for this annotation. In this model, HA-rich extracellular matrix is sensed by CD44; the receptor’s cytoplasmic interactions with merlin/NF2 and cortical-cytoskeletal components translate matrix and cell-density information into growth arrest. Direct HA depletion and CD44-blocking experiments support key parts of this pathway in naked mole-rat fibroblasts. (tian2013highmolecularmasshyaluronanmediates pages 1-7, tian2013highmolecularmasshyaluronanmediates pages 7-9)
Through co-receptor and adaptor functions, mammalian CD44 can influence PI3K–AKT, MAPK/ERK, NF-κB, Rho-family GTPases, receptor-tyrosine-kinase trafficking, cell survival, and migration. The cytoplasmic tail’s phosphorylation state controls ERM association and actin engagement; palmitoylation regulates lipid-raft localization. (skandalis2023cd44intracellulardomain pages 4-5, skandalis2023cd44intracellulardomain pages 5-7, cowman2023functionalorganizationof pages 8-8)
These should not be encoded as constitutively active Cd44 pathways. CD44’s effects depend on cell type, isoform, ligand size, membrane organization, and interacting receptors. Reviews therefore characterize the HA–CD44 axis as a “double-edged sword”: HMW-HA can support homeostasis and suppress inflammation, whereas fragmented HA and variant CD44 contexts can promote inflammation, motility, stemness, or cancer progression. Published October 2023, DOI/URL: https://doi.org/10.3390/ijms242115812. (cirillo2023thehyaluronancd44axis pages 9-11)
Recent work has principally advanced the broader HA/CD44 framework rather than directly characterizing A0AAX6R0R7:
The prominent 2023 Nature study transferring naked mole-rat Has2 into mice is biologically relevant to the ligand side of this axis, but it did not constitute direct functional characterization of A0AAX6R0R7. It should therefore support the therapeutic relevance of naked mole-rat HA metabolism, not be misreported as a Cd44 transgenic experiment.
Human CD44 is widely used experimentally and pathologically as a marker associated with cancer stem-like states. A March 2024 scoping review searched 12,659 records and included 40 clinical studies. More than half associated CD44 positivity with adverse chemotherapy outcomes; the negative association appeared in 80% of chemotherapy-only studies versus 42% of chemotherapy-plus-radiotherapy studies, and in approximately 72–75% of breast and head-and-neck cancer studies. Nevertheless, three studies reported favorable associations and thirteen found no effect, demonstrating substantial heterogeneity. DOI/URL: https://doi.org/10.3390/ijms25063141. (wu2024roleofcd44 pages 9-10, wu2024roleofcd44 pages 1-2)
Experimental therapeutic approaches include CD44-neutralizing antibodies, peptides, siRNA, CAR-T strategies, and HA-coated nanoparticles, micelles, liposomes, or hydrogels that exploit receptor-mediated uptake. A humanized antibody, RG7356, reached Phase I testing in advanced solid tumors but showed limited efficacy, underscoring the difficulty of targeting a widely expressed and context-dependent receptor. (cirillo2023thehyaluronancd44axis pages 9-11, ziranu2024cd44anew pages 9-10)
HA already has real-world medical uses, including local/topical management of chemotherapy-associated mucosal toxicity and established biomaterial uses. HA carriers for anticancer drugs are active translational technologies, but many remain preclinical. Polymer degradation is an important safety issue because shorter HA fragments can favor inflammatory or tumor-promoting signaling. (wu2024roleofcd44 pages 9-10, cirillo2023thehyaluronancd44axis pages 9-11)
Naked-mole-rat high-molecular-mass HA has been proposed as a cytoprotective biomaterial and drug-delivery scaffold, including for glioblastoma, but the 2024 glioblastoma source is a preprint/proposal rather than clinical validation. DOI/URL: https://doi.org/10.20944/preprints202410.0357.v1. (salagean2024uniquepropertiesof pages 5-6)
No naked-mole-rat Cd44/A0AAX6R0R7-specific drug, diagnostic assay, or gene therapy is currently an established clinical implementation. Present applications target human CD44 or use HA as a material; they should not be presented as therapies based on the naked mole-rat receptor sequence.
Molecular function: hyaluronan binding; extracellular-matrix receptor activity; non-catalytic adhesion/co-receptor and cytoskeletal-adaptor function.
Cellular component: integral component of the plasma membrane; cell surface; extracellular/pericellular HA-rich matrix interface; cytoplasmic tail associated with cortical actin and adaptor proteins. Internalized/endosomal and cleavage-derived nuclear localization are plausible conserved secondary states.
Biological processes: cell–matrix adhesion, HA uptake and pericellular-matrix organization, regulation of migration and cytoskeleton, cell-density sensing/contact inhibition, stress-response modulation, and immune-cell homing. In H. glaber, the most relevant specialized annotation is regulation of HA-dependent resistance to transformation and cellular stress. (tian2013highmolecularmasshyaluronanmediates pages 1-7, tian2013highmolecularmasshyaluronanmediates pages 7-9, takasugi2020nakedmoleratveryhighmolecularmass pages 1-2)
Confidence assessment:
Overall, A0AAX6R0R7 should be annotated principally as the cell-surface hyaluronan receptor that converts extracellular-matrix organization into cytoskeletal and growth-control responses, with unusually strong biological relevance in the naked mole-rat’s HA-rich extracellular environment.
References
(skandalis2023cd44intracellulardomain pages 1-2): Spyros S. Skandalis. Cd44 intracellular domain: a long tale of a short tail. Oct 2023. URL: https://doi.org/10.3390/cancers15205041, doi:10.3390/cancers15205041. This article has 45 citations.
(skandalis2023cd44intracellulardomain pages 2-4): Spyros S. Skandalis. Cd44 intracellular domain: a long tale of a short tail. Oct 2023. URL: https://doi.org/10.3390/cancers15205041, doi:10.3390/cancers15205041. This article has 45 citations.
(cowman2023functionalorganizationof pages 5-5): Mary K. Cowman and Eva A. Turley. Functional organization of extracellular hyaluronan, cd44, and rhamm. Proteoglycan Research, Apr 2023. URL: https://doi.org/10.1002/pgr2.4, doi:10.1002/pgr2.4. This article has 38 citations.
(tian2013highmolecularmasshyaluronanmediates pages 1-7): Xiao Tian, Jorge Azpurua, Christopher Hine, Amita Vaidya, Max Myakishev-Rempel, Julia Ablaeva, Zhiyong Mao, Eviatar Nevo, Vera Gorbunova, and Andrei Seluanov. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Jun 2013. URL: https://doi.org/10.1038/nature12234, doi:10.1038/nature12234. This article has 1043 citations and is from a highest quality peer-reviewed journal.
(tian2013highmolecularmasshyaluronanmediates pages 7-9): Xiao Tian, Jorge Azpurua, Christopher Hine, Amita Vaidya, Max Myakishev-Rempel, Julia Ablaeva, Zhiyong Mao, Eviatar Nevo, Vera Gorbunova, and Andrei Seluanov. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Jun 2013. URL: https://doi.org/10.1038/nature12234, doi:10.1038/nature12234. This article has 1043 citations and is from a highest quality peer-reviewed journal.
(takasugi2020nakedmoleratveryhighmolecularmass pages 1-2): Masaki Takasugi, Denis Firsanov, Gregory Tombline, Hanbing Ning, Julia Ablaeva, Andrei Seluanov, and Vera Gorbunova. Naked mole-rat very-high-molecular-mass hyaluronan exhibits superior cytoprotective properties. Nature Communications, May 2020. URL: https://doi.org/10.1038/s41467-020-16050-w, doi:10.1038/s41467-020-16050-w. This article has 129 citations and is from a highest quality peer-reviewed journal.
(marmol2021abundanceandsize pages 2-4): Delphine del Marmol, Susanne Holtze, Nadia Kichler, Arne Sahm, Benoit Bihin, Virginie Bourguignon, Sophie Dogné, Karol Szafranski, Thomas Bernd Hildebrandt, and Bruno Flamion. Abundance and size of hyaluronan in naked mole-rat tissues and plasma. Scientific Reports, Apr 2021. URL: https://doi.org/10.1038/s41598-021-86967-9, doi:10.1038/s41598-021-86967-9. This article has 39 citations and is from a peer-reviewed journal.
(marmol2021abundanceandsize pages 1-2): Delphine del Marmol, Susanne Holtze, Nadia Kichler, Arne Sahm, Benoit Bihin, Virginie Bourguignon, Sophie Dogné, Karol Szafranski, Thomas Bernd Hildebrandt, and Bruno Flamion. Abundance and size of hyaluronan in naked mole-rat tissues and plasma. Scientific Reports, Apr 2021. URL: https://doi.org/10.1038/s41598-021-86967-9, doi:10.1038/s41598-021-86967-9. This article has 39 citations and is from a peer-reviewed journal.
(skandalis2023cd44intracellulardomain pages 4-5): Spyros S. Skandalis. Cd44 intracellular domain: a long tale of a short tail. Oct 2023. URL: https://doi.org/10.3390/cancers15205041, doi:10.3390/cancers15205041. This article has 45 citations.
(skandalis2023cd44intracellulardomain pages 5-7): Spyros S. Skandalis. Cd44 intracellular domain: a long tale of a short tail. Oct 2023. URL: https://doi.org/10.3390/cancers15205041, doi:10.3390/cancers15205041. This article has 45 citations.
(cowman2023functionalorganizationof pages 8-8): Mary K. Cowman and Eva A. Turley. Functional organization of extracellular hyaluronan, cd44, and rhamm. Proteoglycan Research, Apr 2023. URL: https://doi.org/10.1002/pgr2.4, doi:10.1002/pgr2.4. This article has 38 citations.
(cowman2023functionalorganizationof pages 9-9): Mary K. Cowman and Eva A. Turley. Functional organization of extracellular hyaluronan, cd44, and rhamm. Proteoglycan Research, Apr 2023. URL: https://doi.org/10.1002/pgr2.4, doi:10.1002/pgr2.4. This article has 38 citations.
(wu2024roleofcd44 pages 1-2): Zihao Wu, Jillian Lu, Andrew Loo, Nathan Ho, Danny Nguyen, Po Yueh Cheng, Ali I. Mohammed, and Nicola Cirillo. Role of cd44 in chemotherapy treatment outcome: a scoping review of clinical studies. Mar 2024. URL: https://doi.org/10.3390/ijms25063141, doi:10.3390/ijms25063141. This article has 18 citations.
(wu2024roleofcd44 pages 9-10): Zihao Wu, Jillian Lu, Andrew Loo, Nathan Ho, Danny Nguyen, Po Yueh Cheng, Ali I. Mohammed, and Nicola Cirillo. Role of cd44 in chemotherapy treatment outcome: a scoping review of clinical studies. Mar 2024. URL: https://doi.org/10.3390/ijms25063141, doi:10.3390/ijms25063141. This article has 18 citations.
(cirillo2023thehyaluronancd44axis pages 9-11): Nicola Cirillo. The hyaluronan/cd44 axis: a double-edged sword in cancer. International Journal of Molecular Sciences, 24:15812, Oct 2023. URL: https://doi.org/10.3390/ijms242115812, doi:10.3390/ijms242115812. This article has 107 citations.
(ziranu2024cd44anew pages 9-10): Pina Ziranu, Andrea Pretta, Valentina Aimola, Flaviana Cau, Stefano Mariani, Alessandra Pia D’Agata, Claudia Codipietro, Daiana Rizzo, Veronica Dell’Utri, Giorgia Sanna, Giusy Moledda, Andrea Cadoni, Eleonora Lai, Marco Puzzoni, Valeria Pusceddu, Massimo Castagnola, Mario Scartozzi, and Gavino Faa. Cd44: a new prognostic marker in colorectal cancer? Apr 2024. URL: https://doi.org/10.3390/cancers16081569, doi:10.3390/cancers16081569. This article has 47 citations.
(salagean2024uniquepropertiesof pages 5-6): Alex Adrian Salagean, Cezara Anca-Denisa Moldovan, and Mark Slevin. Unique properties of naked mole rat hyaluronan— potential utilization in management of glioblastoma. Unknown journal, Oct 2024. URL: https://doi.org/10.20944/preprints202410.0357.v1, doi:10.20944/preprints202410.0357.v1.